Carregant...

Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases

High dose cyclophosphamide (HiCY) without stem cell rescue has been shown to induce remissions in patients with severe autoimmune disorders (SADS). However, up to 80% of these patients ultimately relapse. Here we review the outcomes of seven patients treated with two cycles and one patient treated w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: DeZern, Amy E, Styler, Michael J, Drachman, Daniel B, Hummers, Laura K, Jones, Richard J, Brodsky, Robert A
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3555191/
https://ncbi.nlm.nih.gov/pubmed/23358715
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!